Brian Poligone
Overview
Explore the profile of Brian Poligone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
509
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu L, Bajorski P, Poligone B
PLoS One
. 2024 Apr;
19(4):e0287444.
PMID: 38630705
The tight control of proliferating keratinocytes is vital to the successful function of the skin. Differentiation of dividing cells is necessary to form a skin barrier. The same dividing cells...
2.
Kim E, Mangold A, DeSimone J, Wong H, Seminario-Vidal L, Guitart J, et al.
JAMA Dermatol
. 2022 Jul;
158(9):1031-1039.
PMID: 35857290
Importance: Given that mycosis fungoides-cutaneous T-cell lymphoma (MF/CTCL) is chronic, there is a need for additional therapies with minimal short- and long-term adverse effects. Topical synthetic hypericin ointment, 0.25%, activated...
3.
Bagot M, Dalle S, Sokol L, Tsianakas A, Musiek A, Ortiz-Romero P, et al.
Dermatol Ther
. 2022 Jun;
35(8):e15634.
PMID: 35695215
No abstract available.
4.
Alexander-Savino C, Chung C, Gilmore E, Carroll S, Poligone B
Dermatol Ther (Heidelb)
. 2022 Feb;
12(3):643-654.
PMID: 35122614
Introduction: Treatment of early-stage mycosis fungoides (MF) requires safe, skin-directed therapies. Medication side effects can lead to underutilization of effective therapies. The objective of this study was to assess the...
5.
Querfeld C, Pacheco T, Haverkos B, Binder G, Angello J, Poligone B
Front Med (Lausanne)
. 2021 Jul;
8:679294.
PMID: 34277658
Topical chlormethine yields high response rates in mycosis fungoides cutaneous T-cell lymphoma with early discontinuation often attributed to skin reactions. We evaluated over 4,000 patients and found an association of...
6.
Gilmore E, Alexander-Savino C, Chung C, Poligone B
JAAD Case Rep
. 2020 Sep;
6(9):878-881.
PMID: 32904169
No abstract available.
7.
Poligone B, Rubio-Gonzalez B, Querfeld C
Dermatol Ther
. 2018 Dec;
32(2):e12804.
PMID: 30549384
Cutaneous T-cell lymphomas (CTCL) are a relatively rare and heterogeneous group of non-Hodgkin lymphomas that typically present in the skin. The majority of patients with CTCL experience pruritus, which can...
8.
Kim Y, Bagot M, Pinter-Brown L, Rook A, Porcu P, Horwitz S, et al.
Lancet Oncol
. 2018 Aug;
19(9):1192-1204.
PMID: 30100375
Background: Cutaneous T-cell lymphomas are rare non-Hodgkin lymphomas with substantial morbidity and mortality in advanced disease stages. We compared the efficacy of mogamulizumab, a novel monoclonal antibody directed against C-C...
9.
Chen L, Hayden M, Gilmore E, Alexander-Savino C, Oleksyn D, Gillespie K, et al.
Carcinogenesis
. 2017 Nov;
39(3):418-428.
PMID: 29186361
Squamous cell carcinoma (SCC) of the skin is a keratinocyte malignancy characterized by tumors presenting on sun-exposed areas with surgery being the mainstay treatment. Despite advances in targeted therapy in...
10.
Vegas O, Poligone B, Blackcloud P, Gilmore E, VanBuskirk J, Ritchlin C, et al.
Brain Behav Immun
. 2017 Oct;
68:238-247.
PMID: 29080684
Acute stress is a physiological response of an organism to adverse conditions, contributing to survival; however, persistence through time may lead to disease. Indeed, exacerbation of inflammatory conditions such as...